Ross Bundy
Chief Executive Officer
Team & advisors
The people behind the world’s first CRISPR analytics platform for quantitative gene editing insight.
CRISPR QC™
Science-first leadership
CRISPR QC™ was founded to give researchers and manufacturers the kinetic data they need to optimize CRISPR workflows—from RNP formation through binding and cleavage—before committing to lengthy cell-based studies.
Our team combines deep CRISPR biochemistry expertise with modern biosensor engineering, backed by a scientific advisory board of leaders in gene editing, diagnostics, and biomanufacturing.
Our missionPlatform
CRISPR Analytics Platform™
Built on the CRISPR-Chip™ biosensor, our platform delivers real-time, quantitative in vitro analysis of CRISPR-Cas interactions.
Leadership
Executive team
Dr. Kiana Aran
Co-founder & Chief Scientific Officer
Advisors
Scientific advisory board
World-class advisors guiding assay development, regulatory strategy, and platform expansion.
Dr. Paul Grint
Dr. Toby Richardson
George Bonaros
Work with our science team
Tell us about your program and we will propose a pilot measurement plan.